TAAP Act / veteran-access language advances legislatively without rescheduling or altering FDA scientific standards.

There's strong agreement across regulatory, law enforcement, and legislative perspectives that Congress will advance language allowing veterans to access psychedelic treatments — without rescheduling the drugs or changing how the FDA evaluates them for safety and effectiveness. This is a targeted workaround, not a broad legal change.

Consensus of 4 agents: fda_reviewer, legislator, dea_officer. 0 dissenting.